Google
ARQT — ARCUTIS BIOTHERAPEUTICS INC (Healthcare >> Biotechnology)
ARQT FAQ
What is ARQT's P/E ratio?
ARCUTIS BIOTHERAPEUTICS INC (ARQT) currently trades at a P/E ratio of 107.06.
What is ARQT's ROE?
ARCUTIS BIOTHERAPEUTICS INC reports a Return on Equity (ROE) of -1.25%.
What is ARQT's dividend yield?
ARCUTIS BIOTHERAPEUTICS INC offers a dividend yield of 0.00%.
What is ARQT's Deepscope Quality Score?
Deepscope rates ARQT's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy ARQT?
Deepscope's AI Timing Score for ARQT is 51 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does ARQT belong to?
ARCUTIS BIOTHERAPEUTICS INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 22.79
Price
1.25
(5.80%)
Day Change
|
|
|---|
ARQT Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 38) và Thời điểm mua ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
Tỷ lệ P/E tương đối cao
Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Lịch sử ROE tương đối thấp
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
Lịch sử Biên lợi nhuận ròng tương đối thấp.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt lắm , ...
| Yếu tố Chất lượng |
|
41% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 22.79 |
| PBV / Sector |
14.00 / 4.71
|
| Earning Per Share | -0.02 |
| PE / Sector |
107.06 / 17.58
|
| PEG or PE/Growth / Sector |
-1.68 / 0.53
|
| Average 1M Daily Value |
37.35 M
GREAT
|
| Average 1W Daily Value |
26.52 M
GREAT
|
| Yếu tố Kỹ thuật |
|
42% |
| Sức khỏe tài chính |
|
43% |
| Khả năng kiếm lợi nhuận |
|
56% |
| Lợi tức cho nhà đầu tư |
|
4% |
| Chi tiết đăng ký |
| Analyze Date | 2026-06-10 09:43:45 |
| Symbol | ARQT |
| Name | ARCUTIS BIOTHERAPEUTICS INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 125.08 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 2,655.52 / 8,889.42 |
| Tin tức, Dự báo ước tính |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 3027 Townsgate Road, Westlake Village, CA, United States, 91361
Phone: 805 418 5006
Website: https://www.arcutis.com
Employees: 354
Sector: Healthcare >> Biotechnology
Description: Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company's lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. It also develops ZORYVE foam seborrheic dermatitis, and scalp and body psoriasis treatment; ARQ-234, a fusion protein that is a potent and highly selective checkpoint agonist of the CD200 receptor. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
